Noema Pharma
SwitzerlandWho owns Noema Pharma?
Noema Pharma is a Swiss Biotech company, currently owned by Jeito Capital since 2023. It changed hands in 2022, when Sofinnova Partners sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Ownership history
2 ownership periods
Sofinnova Partners sold Noema Pharma to NOEMA PHARMA SA in 2022 after 2 years.
More from Jeito I
Other portfolio companies in the same fund.
France
Spain
Germany
US
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Noema Pharma?
Noema Pharma is currently owned by Jeito Capital, through Jeito I, since 2023.
When did Jeito Capital acquire Noema Pharma?
Jeito Capital acquired Noema Pharma in 2023.
Who did Noema Pharma sell to?
Sofinnova Partners sold Noema Pharma to NOEMA PHARMA SA in 2022 (Trade Sale).
Who has owned Noema Pharma over time?
Noema Pharma has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital IX · 2020–2022 · sold to NOEMA PHARMA SA · (Trade Sale); Jeito Capital · via Jeito I · since 2023.